{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T13:44:54Z","timestamp":1782567894905,"version":"3.54.5"},"reference-count":99,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Reprod. Health"],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      To evaluate the effectiveness and safety of the novel protocol\u2014progestin-primed ovarian stimulation (PPOS) protocol during controlled ovarian hyperstimulation (COH), in patients undergoing\n                      <jats:italic>in vitro<\/jats:italic>\n                      fertilization\/intracytopalsmic sperm injection and embryo transfer (IVF\/ICSI-ET).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>By reviewing and analyzing published studies since PPOS protocol was firstly reported in 2015, we compared differences in ovarian stimulation characteristics, embryological features, pregnancy rates, and neonatal outcomes between PPOS protocol and conventional regimens employed in assisted reproductive technology (ART), and discussed the advantages and limitations of PPOS protocol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main finding<\/jats:title>\n                    <jats:p>By adding exogenous progestin (P) during early follicular phase, PPOS scheme provide robust control over preovulatory luteinizing hormone (LH) surge and spontaneous ovulation, which promote oocyte maturation and recovery. Compared to various traditional protocols, PPOS achieved promising clinical pregnancy results, and equivalent rates of birth defect and congenital malformation. Moreover, it possessed significantly lower risk of ovarian hyperstimlation syndrome (OHSS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Not inferior or comparable outcomes indicated that PPOS protocol is a competent alternative for ART with no obviously detrimental impact on oocyte development and embryo quality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/frph.2025.1719930","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:45:10Z","timestamp":1769150710000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Progestin-primed ovarian stimulation protocol in patients undergoing assisted reproductive technology"],"prefix":"10.3389","volume":"7","author":[{"given":"Shanqin","family":"Qi","sequence":"first","affiliation":[{"name":"The First Clinical Medical College, Shandong University of Traditional Chinese Medicine","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Yu","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Shandong University of Traditional Chinese Medicine","place":["Jinan, Shandong, China"]},{"name":"Department of Reproductive Medicine, The Affiliated Taian City Central Hospital of Qingdao University","place":["Taian, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Yang","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Shandong University of Traditional Chinese Medicine","place":["Jinan, Shandong, China"]},{"name":"Department of Obstetrics, The Affiliated Taian City Central Hospital of Qingdao University","place":["Taian, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghan","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Gynecology, The Affiliated Taian City Central Hospital of Qingdao University","place":["Taian, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Preventive Health Care of Traditional Chinese Medicine, Tai\u2019an Hospital of Traditional Chinese Medicine","place":["Taian, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehua","family":"Wang","sequence":"additional","affiliation":[{"name":"Reproduction and Genetics Center, Affiliated Hospital of Shandong University of Traditional Chinese Medicine","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fmed.2019.00197","article-title":"New twists in ovarian stimulation and their practical implications","volume":"6","author":"Pirtea","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/humupd\/dml020","article-title":"Ovarian feedback, mechanism of action and possible clinical implications","volume":"12","author":"Messinis","year":"2006","journal-title":"Hum Reprod Update"},{"key":"B3","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.fertnstert.2006.12.064","article-title":"Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer","volume":"91","author":"Papanikolaou","year":"2009","journal-title":"Fertil Steril"},{"key":"B4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/humrep\/15.3.505","article-title":"Can GnRH agonists act directly on the ovary and contribute to cyst formation?","volume":"15","author":"Mehta","year":"2000","journal-title":"Hum Reprod"},{"key":"B5","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmx017","article-title":"GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type","volume":"23","author":"Lambalk","year":"2017","journal-title":"Hum Reprod Update"},{"key":"B6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4274\/jtgga.2016.0107","article-title":"Pharmacokinetic, pharmacodynamic, and clinical aspects of ovulation induction agents: a review of the literature","volume":"18","author":"Kahyao\u011flu","year":"2017","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.fertnstert.2003.07.002","article-title":"Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome","volume":"80","author":"Bosch","year":"2003","journal-title":"Fertil Steril"},{"key":"B8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.fertnstert.2014.04.010","article-title":"Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles","volume":"102","author":"Reichman","year":"2014","journal-title":"Fertil Steril"},{"key":"B9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.fertnstert.2013.09.007","article-title":"Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization\/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles","volume":"101","author":"Kuang","year":"2014","journal-title":"Fertil Steril"},{"key":"B10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil Steril"},{"key":"B11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.fertnstert.2019.06.009","article-title":"Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology","volume":"112","author":"Yildiz","year":"2019","journal-title":"Fertil Steril"},{"key":"B12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","article-title":"Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses","volume":"27","author":"Ata","year":"2021","journal-title":"Hum Reprod Update"},{"key":"B13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s11596-018-1908-z","article-title":"Effect of progestin-primed ovarian stimulation protocol on outcomes of aged infertile women who failed to get pregnant in the first IVF\/ICSI cycle: a self-controlled study","volume":"38","author":"Chen","year":"2018","journal-title":"Curr Med Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"798434","DOI":"10.3389\/fendo.2022.798434","article-title":"Progestin-primed ovarian stimulation protocol for patients with endometrioma","volume":"13","author":"Yang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"801026","DOI":"10.3389\/fendo.2021.801026","article-title":"Progestin-primed ovarian stimulation versus mild stimulation protocol in advanced age women with diminished ovarian reserve undergoing their first in vitro fertilization cycle: a retrospective cohort study","volume":"12","author":"Tu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12958-017-0291-0","article-title":"Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders","volume":"15","author":"Chen","year":"2017","journal-title":"Reprod Biol Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e2939","DOI":"10.1097\/md.0000000000002939","article-title":"Controlled ovarian stimulation using medroxyprogesterone acetate and hMG in patients with polycystic ovary syndrome treated for IVF","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.fertnstert.2017.06.017","article-title":"Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization\/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation","volume":"108","author":"Zhu","year":"2017","journal-title":"Fertil Steril"},{"key":"B19","doi-asserted-by":"publisher","first-page":"22732","DOI":"10.1038\/s41598-021-02227-w","article-title":"Progestin primed ovarian stimulation using corifollitropin alfa in PCOS women effectively prevents LH surge and reduces injection burden compared to GnRH antagonist protocol","volume":"11","author":"Huang","year":"2021","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00404-018-4856-8","article-title":"New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technology","volume":"298","author":"Iwami","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/humrep\/dez034","article-title":"Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial","volume":"34","author":"Beguer\u00eda","year":"2019","journal-title":"Hum Reprod"},{"key":"B22","doi-asserted-by":"publisher","first-page":"837880","DOI":"10.3389\/fendo.2022.837880","article-title":"Outcomes of a GnRH agonist trigger following a GnRH antagonist or flexible progestin-primed ovarian stimulation cycle","volume":"13","author":"Kalafat","year":"2022","journal-title":"Front Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12958-018-0373-7","article-title":"Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome","volume":"16","author":"Ye","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.2147\/dddt.S338748","article-title":"Progestin-primed ovarian stimulation with clomiphene citrate supplementation may be more feasible for young women with diminished ovarian reserve compared with standard progestin-primed ovarian stimulation: a retrospective study","volume":"15","author":"Lin","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"B25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/jcpt.13567","article-title":"Progestin-primed ovarian stimulation protocol with or without letrozole for patients with normal ovarian reserve: a retrospective cohort study","volume":"47","author":"Jiang","year":"2021","journal-title":"J Clin Pharm Ther"},{"key":"B26","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/cen.13532","article-title":"Progestin-primed ovarian stimulation with or without clomiphene citrate supplementation in normal ovulatory women undergoing in vitro fertilization\/intracytoplasmic sperm injection: a prospective randomized controlled trial","volume":"88","author":"Liu","year":"2018","journal-title":"Clin Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"102049","DOI":"10.1016\/j.jogoh.2020.102049","article-title":"A meta-analysis of the efficacy of progestin-primed ovarian stimulation with medroxyprogesterone acetate in ovulation induction in poor ovarian responders","volume":"50","author":"Cai","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/1471-0528.14622","article-title":"The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial","volume":"124","author":"Dong","year":"2017","journal-title":"BJOG"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.2147\/DDDT.S230129","article-title":"Progestin-primed ovarian stimulation with dydrogesterone versus medroxyprogesterone acetate in women with polycystic ovarian syndrome for in vitro fertilization: a retrospective cohort study","volume":"13","author":"Huang","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"B30","doi-asserted-by":"publisher","first-page":"708704","DOI":"10.3389\/fendo.2021.708704","article-title":"Comparison of dydrogesterone and medroxyprogesterone in the progestin-primed ovarian stimulation protocol for patients with poor ovarian response","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/humrep\/dex367","article-title":"New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF\/ICSI cycles","volume":"33","author":"Yu","year":"2018","journal-title":"Hum Reprod"},{"key":"B32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.fertnstert.2016.10.030","article-title":"Use of utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a \u201cfreeze all\u201d strategy: a randomized controlled dose-finding study of 100\u2005mg versus 200\u2005mg","volume":"107","author":"Zhu","year":"2017","journal-title":"Fertil Steril"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e909","DOI":"10.1097\/md.0000000000000909","article-title":"Utrogestan as an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"94","author":"Zhu","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.rbmo.2014.02.003","article-title":"Novel aspects of the endocrinology of the menstrual cycle","volume":"28","author":"Messinis","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"B35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/humupd\/dmw047","article-title":"New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF","volume":"23","author":"Massin","year":"2017","journal-title":"Hum Reprod Update"},{"key":"B36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.rbmo.2019.03.212","article-title":"Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?","volume":"39","author":"La Marca","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"B37","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.fertnstert.2012.05.019","article-title":"Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of frozen thawed versus fresh embryos generated through in vitro fertilization treatment: a systematic review and meta-analysis","volume":"98","author":"Maheshwari","year":"2012","journal-title":"Fertil Steril"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/humrep\/der126","article-title":"Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis","volume":"26","author":"Labarta","year":"2011","journal-title":"Hum Reprod"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.12659\/msm.906602","article-title":"Lipidomic components alterations of human follicular fluid reveal the relevance of improving clinical outcomes in women using progestin-primed ovarian stimulation compared to short-term protocol","volume":"24","author":"Wen","year":"2018","journal-title":"Med Sci Monit"},{"key":"B40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3109\/00016347309158325","article-title":"\u201cTriggering\u201d of ovulation after infusion of synthetic luteinizing hormone releasing factor (LRF)","volume":"52","author":"Nakano","year":"1973","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B41","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1210\/jcem-67-3-524","article-title":"Evidence of differential control of FSH and LH secretion by gonadotropin-releasing hormone (GnRH) from the use of a GnRH antagonist","volume":"67","author":"Hall","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jogoh.2018.10.008","article-title":"Progestin-primed ovarian stimulation is a feasible method for poor ovarian responders undergoing in IVF\/ICSI compared to a GnRH antagonist protocol: a retrospective study","volume":"48","author":"Huang","year":"2019","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"B43","doi-asserted-by":"publisher","first-page":"705264","DOI":"10.3389\/fendo.2021.705264","article-title":"Comparison of the cumulative live birth rates of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols in patients with low prognosis","volume":"12","author":"Du","year":"2021","journal-title":"Front Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/14647273.2020.1794060","article-title":"Effectiveness of the flexible progestin primed ovarian stimulation protocol compared to the flexible GnRH antagonist protocol in women with decreased ovarian reserve","volume":"25","author":"Turkgeldi","year":"2020","journal-title":"Hum Fertil"},{"key":"B45","doi-asserted-by":"publisher","first-page":"797227","DOI":"10.3389\/fendo.2021.797227","article-title":"The comparison of fixed and flexible progestin primed ovarian stimulation on mature oocyte yield in women at risk of premature ovarian insufficiency","volume":"12","author":"Kalafat","year":"2022","journal-title":"Front Endocrinol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/09513590.2020.1822802","article-title":"Granulosa cells apoptosis and follicular fluid hormones: comparison of progestin-primed ovarian stimulation versus GnRH antagonist protocols","volume":"37","author":"Li","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1530\/acta.0.0900696","article-title":"Differential properties of human chorionic gonadotrophin and human luteinizing hormone binding to plasma membranes of bovine corpora lutea","volume":"90","author":"Rao","year":"1979","journal-title":"Acta Endocrinol (Copenh)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5935\/1518-0557.20210057","article-title":"Progestin-primed ovarian stimulation is a non-inferior alternative to the GnRH antagonist protocol in patients undergoing assisted reproductive techniques: a retrospective study","volume":"26","author":"Caetano","year":"2022","journal-title":"JBRA Assist Reprod"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1093\/humrep\/deq123","article-title":"Predicting aneuploidy in human oocytes: key factors which affect the meiotic process","volume":"25","author":"Gianaroli","year":"2010","journal-title":"Hum Reprod"},{"key":"B50","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12958-019-0518-3","article-title":"Progestin-primed ovarian stimulation vs mild stimulation in women with advanced age above 40: a retrospective cohort study","volume":"17","author":"Peng","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3389\/fendo.2019.00796","article-title":"Progestin vs. gonadotropin-releasing hormone antagonist for the prevention of premature luteinizing hormone surges in poor responders undergoing in vitro fertilization treatment: a randomized controlled trial","volume":"10","author":"Chen","year":"2019","journal-title":"Front Endocrinol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11596-019-2055-x","article-title":"Flexible GnRH antagonist protocol versus progestin-primed ovarian stimulation (PPOS) protocol in patients with polycystic ovary syndrome: comparison of clinical outcomes and ovarian response","volume":"39","author":"Xiao","year":"2019","journal-title":"Curr Med Sci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00404-020-05939-y","article-title":"Effectiveness of progesterone-primed ovarian stimulation in assisted reproductive technology: a systematic review and meta-analysis","volume":"303","author":"Cui","year":"2021","journal-title":"Arch Gynecol Obstet"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(99)04345-7","article-title":"Deliveries and children born after in-vitro fertilisation in Sweden 1982\u201395: a retrospective cohort study","volume":"354","author":"Bergh","year":"1999","journal-title":"Lancet"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1093\/humrep\/14.7.1896","article-title":"Danish national in-vitro fertilization registry 1994 and 1995: a controlled study of births, malformations and cytogenetic findings","volume":"14","author":"Westergaard","year":"1999","journal-title":"Hum Reprod"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s00404-017-4537-z","article-title":"Neonatal outcomes and congenital malformations in children born after human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles","volume":"296","author":"Zhang","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e11906","DOI":"10.1097\/md.0000000000011906","article-title":"Comparison of neonatal outcomes and live-birth defects after progestin-primed ovarian stimulation versus conventional ovarian stimulation for in vitro fertilization","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.2147\/DDDT.S263138","article-title":"Live-birth outcomes and congenital malformations after progestin-primed ovarian stimulation in maternal endometriosis","volume":"14","author":"Liang","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"B59","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13048-020-00620-z","article-title":"Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols","volume":"13","author":"Mathieu d\u2019Argent","year":"2020","journal-title":"J Ovarian Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.rbmo.2018.12.044","article-title":"Evaluation of the cost-effectiveness of ovulation suppression with progestins compared with GnRH analogs in assisted reproduction cycles","volume":"38","author":"Evans","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"B61","doi-asserted-by":"publisher","first-page":"702558","DOI":"10.3389\/fendo.2021.702558","article-title":"Progestin-primed ovarian stimulation protocol for patients in assisted reproductive technology: a meta-analysis of randomized controlled trials","volume":"12","author":"Guan","year":"2021","journal-title":"Front Endocrinol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"Cd001750","DOI":"10.1002\/14651858.CD001750.pub4","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"4","author":"Al-Inany","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/humrep\/dew051","article-title":"Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF\/ICSI cycles","volume":"31","author":"Toftager","year":"2016","journal-title":"Hum Reprod"},{"key":"B64","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0010-7824(95)00255-3","article-title":"Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions","volume":"53","author":"Heikinheimo","year":"1996","journal-title":"Contraception"},{"key":"B65","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1365-2826.2005.01287.x","article-title":"Progesterone can block the preovulatory gonadotropin-releasing hormone\/luteinising hormone surge in the ewe by a direct inhibitory action on oestradiol-responsive cells within the hypothalamus","volume":"17","author":"Richter","year":"2005","journal-title":"J Neuroendocrinol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1210\/jcem-58-2-378","article-title":"Progesterone modulation of pulsatile luteinizing hormone secretion in normal women","volume":"58","author":"Soules","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"B67","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/endo.140.2.6490","article-title":"Progesterone can block transmission of the estradiol-induced signal for luteinizing hormone surge generation during a specific period of time immediately after activation of the gonadotropin-releasing hormone surge-generating system","volume":"140","author":"Harris","year":"1999","journal-title":"Endocrinology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"8096","DOI":"10.1038\/s41598-017-08805-1","article-title":"Hypothalamic effects of progesterone on regulation of the pulsatile and surge release of luteinising hormone in female rats","volume":"7","author":"He","year":"2017","journal-title":"Sci Rep"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1007\/s10815-025-03612-4","article-title":"A comparison of the effects of progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in assisted reproductive technology: a systematic review and meta-analysis","volume":"42","author":"Wang","year":"2025","journal-title":"J Assist Reprod Genet"},{"key":"B70","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3389\/fendo.2020.00287","article-title":"Cumulative live birth rates after the first ART cycle using flexible GnRH antagonist protocol vs. standard long GnRH agonist protocol: a retrospective cohort study in women of different ages and various ovarian reserve","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B71","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jfma.2022.08.023","article-title":"Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: risk of premature LH surge and outcome of oocyte retrieval","volume":"122","author":"Kao","year":"2023","journal-title":"J Formos Med Assoc"},{"key":"B72","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/humrep\/deae286","article-title":"Flexible progestin-primed ovarian stimulation versus a GnRH antagonist protocol in predicted suboptimal responders undergoing freeze-all cycles: a randomized non-inferiority trial","volume":"40","author":"Cai","year":"2025","journal-title":"Hum Reprod"},{"key":"B73","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/ijgo.14903","article-title":"Outcomes and cost-effectiveness comparisons of progestin-primed ovarian stimulation, GnRH antagonist protocol, and luteal phase stimulation for fertility preservation","volume":"163","author":"Zhao","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/humrep\/deaa068","article-title":"Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation","volume":"35","author":"La Marca","year":"2020","journal-title":"Hum Reprod"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/humrep\/deae047","article-title":"Ovarian response and embryo ploidy following oral micronized progesterone-primed ovarian stimulation versus GnRH antagonist protocol. A prospective study with repeated ovarian stimulation cycles","volume":"39","author":"Vidal","year":"2024","journal-title":"Hum Reprod"},{"key":"B76","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.rbmo.2022.03.003","article-title":"Euploidy rates among preimplantation genetic testing for aneuploidy cycles with oral dydrogesterone primed ovarian stimulation or GnRH antagonist protocol","volume":"45","author":"Yang","year":"2022","journal-title":"Reprod Biomed Online"},{"key":"B77","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/humupd\/dmq032","article-title":"Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence","volume":"17","author":"Qiao","year":"2011","journal-title":"Hum Reprod Update"},{"key":"B78","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/humupd\/dmn015","article-title":"Follicle dynamics and anovulation in polycystic ovary syndrome","volume":"14","author":"Franks","year":"2008","journal-title":"Hum Reprod Update"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1224858","DOI":"10.3389\/fendo.2023.1224858","article-title":"Efficacy of progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing in vitro fertilization: a systematic review and meta-analysis","volume":"14","author":"Yang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B80","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1095\/biolreprod67.1.119","article-title":"Progesterone blocks the estradiol-stimulated luteinizing hormone surge by disrupting activation in response to a stimulatory estradiol signal in the ewe","volume":"67","author":"Richter","year":"2002","journal-title":"Biol Reprod"},{"key":"B81","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1095\/biolreprod.103.023390","article-title":"Progesterone promotes oocyte maturation, but not ovulation, in nonhuman primate follicles without a gonadotropin surge","volume":"71","author":"Borman","year":"2004","journal-title":"Biol Reprod"},{"key":"B82","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1095\/biolreprod.109.082354","article-title":"Effect of elevated circulating progesterone concentration on bovine blastocyst development and global transcriptome following endoscopic transfer of in vitro produced embryos to the bovine oviduct","volume":"83","author":"Carter","year":"2010","journal-title":"Biol Reprod"},{"key":"B83","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1095\/biolreprod.110.087411","article-title":"Expression, regulation, and function of progesterone receptors in bovine cumulus oocyte complexes during in vitro maturation","volume":"84","author":"Aparicio","year":"2011","journal-title":"Biol Reprod"},{"key":"B84","first-page":"74","article-title":"The effects of progesterone on oocyte maturation and embryo development","volume":"7","author":"Salehnia","year":"2013","journal-title":"Int J Fertil Steril"},{"key":"B85","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1530\/reprod\/119.2.261","article-title":"Effects of androgens, progesterone and their antagonists on the developmental competence of in vitro matured bovine oocytes","volume":"119","author":"Silva","year":"2000","journal-title":"J Reprod Fertil"},{"key":"B86","doi-asserted-by":"publisher","first-page":"104833","DOI":"10.1016\/j.rbmo.2025.104833","article-title":"Adverse effects of progestin-primed ovarian stimulation: combination of clinical study and single-cell analysis","volume":"51","author":"Handa","year":"2025","journal-title":"Reprod BioMed Online"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/humrep\/deaa085","article-title":"The mitochondrial DNA copy number of cumulus granulosa cells may be related to the maturity of oocyte cytoplasm","volume":"35","author":"Lan","year":"2020","journal-title":"Hum Reprod"},{"key":"B88","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.fertnstert.2023.11.013","article-title":"Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline","volume":"121","year":"2024","journal-title":"Fertil Steril"},{"key":"B89","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.fertnstert.2020.04.004","article-title":"Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes","volume":"114","author":"Schirmer","year":"2020","journal-title":"Fertil Steril"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1507857","DOI":"10.3389\/fendo.2025.1507857","article-title":"Minimising OHSS in women with PCOS","volume":"16","author":"Leathersich","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B91","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3109\/09513590.2015.1025379","article-title":"Ovulation induction and luteal support with GnRH agonist in patients at high risk for hyperstimulation syndrome","volume":"31","author":"Fusi","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/03009734.2020.1736696","article-title":"Gonadotropin-releasing hormone agonist for ovulation trigger\u2014OHSS prevention and use of modified luteal phase support for fresh embryo transfer","volume":"125","author":"Castillo","year":"2020","journal-title":"Ups J Med Sci"},{"key":"B93","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.rbmo.2009.11.018","article-title":"Cycles triggered with GnRH agonist: exploring low-dose HCG for luteal support","volume":"20","author":"Castillo","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"B94","doi-asserted-by":"publisher","first-page":"e038153","DOI":"10.1136\/bmjopen-2020-038153","article-title":"Comparison of a progestin-primed ovarian stimulation protocol with a flexible GnRH antagonist protocol in patients with polycystic ovary syndrome who are participating in an IVF programme: study protocol for a randomised controlled trial","volume":"10","author":"Wang","year":"2020","journal-title":"BMJ Open"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e918705","DOI":"10.12659\/msm.918705","article-title":"Effect of switching from a progestin-primed ovarian stimulation protocol to a modified ultra-long protocol among women who had 1 progestin-primed ovarian stimulation (PPOS) failure verses those who had 2 PPOS failures","volume":"26","author":"Shen","year":"2020","journal-title":"Med Sci Monit"},{"key":"B96","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/s13063-018-2850-x","article-title":"Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial","volume":"19","author":"Wang","year":"2018","journal-title":"Trials"},{"key":"B97","doi-asserted-by":"publisher","first-page":"100540","DOI":"10.1016\/j.repbio.2021.100540","article-title":"A comprehensive evaluation of progestin-primed ovarian stimulation protocol in patients with or without PCOS undergoing in vitro fertilization","volume":"21","author":"Zhu","year":"2021","journal-title":"Reprod Biol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00404-019-05065-4","article-title":"Different progestin-primed ovarian stimulation protocols in infertile women undergoing in vitro fertilization\/intracytoplasmic sperm injection: an analysis of 1188 cycles","volume":"299","author":"Guo","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"B99","doi-asserted-by":"publisher","first-page":"690575","DOI":"10.3389\/fendo.2021.690575","article-title":"Fixed gonadotropin-releasing hormone antagonist protocol versus flexible progestin-primed ovarian stimulation protocol in patients with asynchronous follicular development during controlled ovulation stimulation: a retrospective study","volume":"12","author":"Dong","year":"2021","journal-title":"Front Endocrinol"}],"container-title":["Frontiers in Reproductive Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2025.1719930\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:09:49Z","timestamp":1771924189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2025.1719930\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":99,"alternative-id":["10.3389\/frph.2025.1719930"],"URL":"https:\/\/doi.org\/10.3389\/frph.2025.1719930","relation":{},"ISSN":["2673-3153"],"issn-type":[{"value":"2673-3153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"article-number":"1719930"}}